Nonarteritic anterior ischemic optic neuropathy: Associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation

Journal of Laboratory and Clinical Medicine

Volumn 143, Issue 3, 2004, Pages 184-192

  Glueck, Charles J ^a,b   Wang, Ping ^a   Bell, Howard ^a   Rangaraj, Venkat ^a   Goldenberg, Naila ^a  

^a JEWISH HOSPITAL   (United States)

^b Cholesterol Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); PROTHROMBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EVALUATION; FEMALE; GENE MUTATION; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MALE; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; POLYMERASE CHAIN REACTION; PREGNANCY; RACE; THROMBOPHILIA;

EID: 1542506140     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2003.10.015     Document Type: Article

References (38)

1. Glueck CJ, Fontaine RN, Wang P. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke. Thromb Haemost 2001;85:256-9.
2. Reino S, Munoz-Rodriquez FJ, Cervera R, Espinosa G, Font J, Ingelmo M. Optic neuropathy in the "primary" antiphospholipid syndrome: Report of a case and review of the literature. Clin Rheumatol 1997;16:629-31.
3. Srinivasan S, Fern A, Watson WH, McColl MD. Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation. Am J Ophthalmol 2001;131:671-3.
4. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 2000;107:1588-92.
5. Besbas N, Anlar B, Apak A, Kansu T. Optic neuropathy in primary antiphospholipid syndrome in childhood. J Child Neurol 2001;16:690-3.
6. Killer HE, Huber A, Portman C, Forrer A, Flammer J. Bilateral non-arteritic anterior ischemic optic neuropathy in a patient with autoimmune thrombocytopenia. Eur J Ophthalmol 2000;10:180-2.
7. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83:1287-90.
8. Weger M, Stanger O, Deutschmann H, Simon M, Renner W, Schmut O, et al. Hyperhomocyst(e)inemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol 2001;85:803-6.
9. Worrall BB, Moazami G, Odel JG, Behrens MM. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol 1997;17:162-5.
10. Aziz A, Conway MD, Robertson HJ, Espinoza LR, Wilson WA. Acute optic neuropathy and transverse myleopathy in patients with antiphospholipid antibody syndrome: favorable outcome after treatment with anticoagulants and glucocorticoids. Lupus 2000;9:307-10.
11. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999;106:739-42.
12. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-53.
13. Hoibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial. Thromb Haemost 2001;85:775-81.
14. Glueck O, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999;117:43-9.
15. Rodeghiero F, Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999;130:643-50.
16. de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999;93:1271-6.
17. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthoped 2001;386:19-33.
18. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44-8.
19. Glueck CJ, Iyengar S, Goldenberg N, Sieve-Smith L, Wang P. Pseudotumor cerebri: associations with coagulation disorders and polycystic ovary syndrome. J Lab Clin Med 2003;142:35-45.
20. Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in children and adults. Thromb Haemost 1999;81:739-44.
21. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein (a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993;43:236-46.
22. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
23. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
24. Jin Y, Dietz HC, Nurden A, Bray PF. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993;82:2281-8.
25. Brandt G, Gruppo R, Glueck CJ, Stroop D, Becker A, Pillow A, et al. Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in children. Thromb Haemost 1998;79:567-70.
26. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01-3670. Bethesda, Md: National Institutes of Health; 2001.
27. The Lipid Research Clinics Population Studies Data Book. Vol 1: The prevalence study. NIH Publication 80. Washington, DC: Department of Health and Human Services, US Public Health Service: 1980, p. 1527.
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
29. Stokes ME, Davis CS, Koch GG. Categorical analysis using the SAS system. Cary NC: SAS institute Inc; 1995.
30. Andreassi MG, Botto N, Cocci F, Battaglia D, Antionioli E, Masetti S, et al. Methylenetetraohydrofolate reductase C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 2003;112:171-7.
31. Post MS, Rosing J, Van Der Mooren MJ, Zweegman S, Van Baal WM, Kenemans P, et al. Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women. Br J Haematol 2002;119:1017-23.
32. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE. Estrogen replacement therapy, thrombophilia, and atherothrombosis. Metabolism 2002;51:724-32.
33. Feldon SE. Anterior ischemic optic neuropathy: trouble waiting to happen. Ophthalmology 1999;106:651-2.
34. Wang MY, Sadun F, Levin LB, LaBree L, Feldon SE. Occurrence of familial nonarteritic anterior ischemic optic neuropathy in a case series. J Neuroophthalmol 1999;19:144-7.
35. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 1997;17:250-3.
36. Haas A, Walzl M, Jesenik F, Walzl B, Berghold A, Bergloss J, et al. Application of HELP in non arteritic anterior ischemic optic neuropathy: a prospective randomized controlled study. Graefes Arch Clin Exp Ophthalmol 1997;235:14-9.
37. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:212-7.
38. Newman NJ, Scherer R, Langenberg R, Kelman S, Feldon S, Kaufman D, et al. The fellow eye in NAION: report for the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-28.